The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Intermediates Market Research Report 2025

Global Pharmaceutical Intermediates Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1409393

No of Pages : 98

Ask Your Query

Synopsis

Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.

The global Pharmaceutical Intermediates market was valued at US$ 182100 million in 2023 and is anticipated to reach US$ 280690 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.

Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.

China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.

In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Intermediates.

Report Scope

The Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Lonza
  • Catalent
  • Patheon
  • Jubilant
  • Granules
  • Ganesh
  • Chemcon
  • BASF
  • Porton
  • Lianhetech
  • ABA Chem
  • Tianma
  • Jiujiujiu
  • Alpha
  • Jiuzhou
  • Yongtai

Segment by Type

  • GMP
  • Non-GMP

Segment by Application

  • Antibiotics
  • Antipyretic Analgesics
  • Vitamins
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Pharmaceutical Intermediates Market Overview
1.1 Product Overview and Scope of Pharmaceutical Intermediates
1.2 Pharmaceutical Intermediates Segment by Type
1.2.1 Global Pharmaceutical Intermediates Market Value Comparison by Type (2024-2030)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates Segment by Application
1.3.1 Global Pharmaceutical Intermediates Market Value by Application: (2024-2030)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Intermediates Revenue 2019-2030
1.4.2 Global Pharmaceutical Intermediates Sales 2019-2030
1.4.3 Global Pharmaceutical Intermediates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Intermediates Market Competition by Manufacturers
2.1 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Intermediates Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Intermediates Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Intermediates, Product Type & Application
2.7 Pharmaceutical Intermediates Market Competitive Situation and Trends
2.7.1 Pharmaceutical Intermediates Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Intermediates Players Market Share by Revenue
2.7.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Intermediates Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Intermediates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Intermediates Global Pharmaceutical Intermediates Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Intermediates Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Intermediates Sales by Region: 2025-2030
3.3 Global Pharmaceutical Intermediates Global Pharmaceutical Intermediates Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Intermediates Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Intermediates Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Intermediates Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Intermediates Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Intermediates Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Intermediates Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Intermediates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Intermediates Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Intermediates Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Intermediates Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Intermediates Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Intermediates Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Intermediates Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Intermediates Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Intermediates Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Intermediates Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Intermediates Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Intermediates Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Intermediates Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Intermediates Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Intermediates Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Intermediates Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Intermediates Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Intermediates Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Intermediates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lonza Pharmaceutical Intermediates Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Corporation Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Catalent Pharmaceutical Intermediates Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 Patheon
6.3.1 Patheon Corporation Information
6.3.2 Patheon Description and Business Overview
6.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Patheon Pharmaceutical Intermediates Product Portfolio
6.3.5 Patheon Recent Developments/Updates
6.4 Jubilant
6.4.1 Jubilant Corporation Information
6.4.2 Jubilant Description and Business Overview
6.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jubilant Pharmaceutical Intermediates Product Portfolio
6.4.5 Jubilant Recent Developments/Updates
6.5 Granules
6.5.1 Granules Corporation Information
6.5.2 Granules Description and Business Overview
6.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Granules Pharmaceutical Intermediates Product Portfolio
6.5.5 Granules Recent Developments/Updates
6.6 Ganesh
6.6.1 Ganesh Corporation Information
6.6.2 Ganesh Description and Business Overview
6.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ganesh Pharmaceutical Intermediates Product Portfolio
6.6.5 Ganesh Recent Developments/Updates
6.7 Chemcon
6.6.1 Chemcon Corporation Information
6.6.2 Chemcon Description and Business Overview
6.6.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chemcon Pharmaceutical Intermediates Product Portfolio
6.7.5 Chemcon Recent Developments/Updates
6.8 BASF
6.8.1 BASF Corporation Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BASF Pharmaceutical Intermediates Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Porton
6.9.1 Porton Corporation Information
6.9.2 Porton Description and Business Overview
6.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Porton Pharmaceutical Intermediates Product Portfolio
6.9.5 Porton Recent Developments/Updates
6.10 Lianhetech
6.10.1 Lianhetech Corporation Information
6.10.2 Lianhetech Description and Business Overview
6.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lianhetech Pharmaceutical Intermediates Product Portfolio
6.10.5 Lianhetech Recent Developments/Updates
6.11 ABA Chem
6.11.1 ABA Chem Corporation Information
6.11.2 ABA Chem Pharmaceutical Intermediates Description and Business Overview
6.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ABA Chem Pharmaceutical Intermediates Product Portfolio
6.11.5 ABA Chem Recent Developments/Updates
6.12 Tianma
6.12.1 Tianma Corporation Information
6.12.2 Tianma Pharmaceutical Intermediates Description and Business Overview
6.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tianma Pharmaceutical Intermediates Product Portfolio
6.12.5 Tianma Recent Developments/Updates
6.13 Jiujiujiu
6.13.1 Jiujiujiu Corporation Information
6.13.2 Jiujiujiu Pharmaceutical Intermediates Description and Business Overview
6.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jiujiujiu Pharmaceutical Intermediates Product Portfolio
6.13.5 Jiujiujiu Recent Developments/Updates
6.14 Alpha
6.14.1 Alpha Corporation Information
6.14.2 Alpha Pharmaceutical Intermediates Description and Business Overview
6.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Alpha Pharmaceutical Intermediates Product Portfolio
6.14.5 Alpha Recent Developments/Updates
6.15 Jiuzhou
6.15.1 Jiuzhou Corporation Information
6.15.2 Jiuzhou Pharmaceutical Intermediates Description and Business Overview
6.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiuzhou Pharmaceutical Intermediates Product Portfolio
6.15.5 Jiuzhou Recent Developments/Updates
6.16 Yongtai
6.16.1 Yongtai Corporation Information
6.16.2 Yongtai Pharmaceutical Intermediates Description and Business Overview
6.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Yongtai Pharmaceutical Intermediates Product Portfolio
6.16.5 Yongtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Intermediates Industry Chain Analysis
7.2 Pharmaceutical Intermediates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Intermediates Production Mode & Process
7.4 Pharmaceutical Intermediates Sales and Marketing
7.4.1 Pharmaceutical Intermediates Sales Channels
7.4.2 Pharmaceutical Intermediates Distributors
7.5 Pharmaceutical Intermediates Customers
8 Pharmaceutical Intermediates Market Dynamics
8.1 Pharmaceutical Intermediates Industry Trends
8.2 Pharmaceutical Intermediates Market Drivers
8.3 Pharmaceutical Intermediates Market Challenges
8.4 Pharmaceutical Intermediates Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock